Mepolizumab (Nucala) 100mg is an innovative treatment option for individuals with severe asthma. This medication, administered through subcutaneous injections, targets the interleukin-5 pathway. By inhibiting this inflammatory molecule, Mepolizumab helps to control airway inflammation and improve breathing capacity . Clinical trials have shown that

Zegfrovy Sunvozertinib, a quite new therapeutic agent, is generating significant interest within the oncology community. Its mechanism of action mostly involves selective inhibition of skin growth factor receptor (EGFR) protein activity, showing hope in treating various cancerous forms. Early clinical investigations have demonstrated encouraging re